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httcense.Abstract Purpose: To evaluate magnetic resonance spectroscopy (MRS) in the assessment of
brain tumors and grading brain glioma.
Patients and methods: Retrospective study was done for 42 patients with diagrammatic representa-
tions suggested by the author for the assessment of MRS data.
Results: Pathology grading was correlated with metabolic ratios in cases of brain glioma. Ratios
higher than 1.5 for either Cho/Cr or Cho/NAA were consistent with tumors and ratios higher than
2 were consistent with high grade glioma or metastases.
Conclusion: MRS can be used to grade cases of brain glioma. Diagrammatic representations and a
diagnostic approach were suggested by the author to simplify clinical practice.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Brain tumors remain a signiﬁcant cause of morbidity and mor-
tality and are often refractory to treatment. The grading of
brain tumor has an important implication in clinical manage-
ment (1).
The gold standard of tumor grading is histopathologic
diagnosis requiring a biopsy with open or stereotactic neuro-
surgical procedure (2).07321719.
.com.
of the Egyptian Society of
g by Elsevier
Radiology and Nuclear Medicine.
p://dx.doi.org/10.1016/j.ejrnm.2012Metabolic imaging is emerging as a promising diagnostic
tool for the evaluation of cerebral gliomas (3).
Currently, magnetic resonance spectroscopy (MRS) is an
important modality in evaluating and grading brain tumors
(2,4).
Because conventional MRI and other methods of biomedi-
cal imaging allow for only vague identiﬁcation and localization
of tumors, biopsies were routinely required to diagnose tumors.
Unfortunately, many tumors may be inaccessible for biopsy.
The grading of tumors with MRS had the additional advantage
of being a noninvasive diagnostic procedure. MRS is an impor-
tant modality for the evaluation of tumor type and grade, as
well as for targeting and evaluating response to therapy (5).
To the author’s knowledge, there are no enough studies con-
cerning the application of MRS metabolic ratios in the staging
of brain glioma with pathology correlation. In addition, there
was no simple diagnostic approach for MRS of brain tumors
and previous representations were not satisfactory.Production and hosting by Elsevier B.V.
.07.006
Table 1 MRS data of 15 cases of brain glioma (group A).
Patient no./age (Y)/sex Cho Cr NAA Cho/Cr Cho/NAA Tumor grade
1/49/M 52 18 20 2.89 2.60 4
2/43/F 170 30 23 5.67 7.39 4
3/42/F 218 44 63 4.95 3.46 4
4/37/M 98 43 24 2.28 4.08 4
5/38/M 64 30 30 2.13 2.13 4
6/59/M 30 5 14 6.00 2.14 4
7/24/F 45 22 12 2.04 3.75 3
8/38/M 77 35 26 2.20 2.96 3
9/40/F 47 24 18 1.96 2.61 3
10/45/M 41 20 21 2.05 1.95 3
11/57/F 88 45 48 1.96 1.83 2
12/22/M 99 60 60 1.65 1.65 2
13/51/F 66 40 41 1.65 1.61 2
14/42/M 43 26 25 1.65 1.72 1
15/46/F 74 49 49 1.51 1.51 1
Table 2 Mean metabolic ratios in brain glioma (group A) ± standard error.
Ratio Grade 1 (n= 2) Grade 2 (n= 3) Grade 3 (n= 4) Grade 4 (n= 6)
Cho/Cr 1.58 ± 0.07 1.75 ± 0.10 2.06 ± 0.05 3.99 ± 0.72
Cho/NAA 1.62 ± 0.11 1.70 ± 0.07 2.82 ± 0.37 3.63 ± 0.81
Table 3 MRS data of normal side in 7 cases of brain glioma
(group A).
No Age/Sex Cho Cr NAA Cho/Cr Cho/NAA
1 49/M 43 60 108 0.72 0.40
2 43/F 77 88 87 0.88 0.89
3 38/M 10 10 24 1.00 0.42
4 40/F 41 36 52 1.14 0.79
5 45/M 25 40 57 0.63 0.44
6 51/F 80 95 155 0.84 0.52
7 46/F 34 50 64 0.68 0.53
Table 4 Mean ratios of normal brain in cases of brain glioma
(group A) ± standard error.
Cho/Cr 0.84 ± 0.07
Cho/NAA 0.57 ± 0.07
Table 5 MRS data of 7 patients with post radiation necrosis
(group D).
No Age/Sex Cho Cr NAA Cho/Cr Cho/NAA
1 49/F 0 0 0 Void Void
2 39/M 9 10 10 0.90 0.90
3 41/M 0 0 0 Void Void
4 37/F 5 7 14 0.71 0.36
5 45/M 1 1 1 1 1
6 43/F 0 4 8 Void Void
7 53/M 2 6 9 0.33 0.22
Table 6 Mean ratios in cases with post radiation necrosis
(group D) ± standard error.
Cho/Cr 0.74 ± 0.15
Cho/NAA 0.62 ± 0.19
Table 7 MRS data of normal side in 3 cases of post radiation
necrosis (group D).
No Age/Sex Cho Cr NAA Cho/Cr Cho/NAA
1 49/F 46 60 68 0.77 0.68
2 41/M 31 36 50 0.86 0.62
3 45/M 57 64 84 0.89 0.68
604 A. ShokryThe purpose of this study was twofold, ﬁrstly to evaluate
MRS in the differentiation of brain tumors and grading brain
gliomas and secondly to make diagrammatic representations
and a diagnostic approach that provide an easy diagnosis, to
be suggested for clinical practice.
2. Patients and methods
2.1. Study population
Retrospective study of 42 patients (20 females and 22 males
with ages ranging from 21–62 years, mean age 46 years) of
brain tumors was done at the National Cancer Institute, Cairo
University.
Patients were assigned to 1 of 4 groups: Group (A) included
15 cases of gliomas before therapy. Group (B) included 10 cases
of meningioma. Group (C) included 10 patients of brain metas-
tases. Group (D) included 7 patients of treated gliomas, with
Table 8 Mean ratios of normal brain in cases of post
radiation necrosis (group D) standard error.
Cho/Cr 0.84 ± 0.04
Cho/NAA 0.66 ± 0.02
MRS of brain tumors: Diagrammatic representations and diagnostic approach 605post radiation necrosis. All cases of Groups (A) and (B) were
pathologically proven by previous surgical or stereotactic
biopsy. In groups (C) and (D), diagnosis was based on clinical
history, other investigations and follow up.Diagnosis was basedFig. 2 Forty-three year old female with glioma grade 4 (glioblasto
multiple voxel MRS showed increased (Cho) peak and decreased othe
Fig. 1 Forty-nine year old male with grade 4 glioma. Normal spe
contralateral hemisphere. (B) The spectra appeared normal with a hig
(Cho) and myoinositol (M-Ino) peaks.also on the absence of recurrent disease on regular and serial fol-
low up evaluation in cases of group (D). Group (D) was taken in
an attempt to make diagrammatic representations for MRS of
necrotic lesions to complement other diagrams of MRS.
No informed consent was taken since it was a retrospective
study, approved by the institutional ethics committee.
2.2. Imaging methods
MRI and MRS studies were done using single voxel and / or
multivoxel techniques on a superconducting 1.5 Tesla, MRma multiforme). (A) Voxel on the lesion. (B) and (C) single and
r metabolite peaks.
ctra were taken from normal brain tissue. (A) Voxel on normal
h N-acetyl aspartate (NAA), creatine (Cr) peaks and low choline
Fig. 3 Forty-two year old male with a brain stem glioma grade 2 (oligodendroglioma). (A) Voxel on the lesion. (B) MRS showed high
(Cho) with low (NAA) and (Cr).
Fig. 4 Forty-nine year old female with treated right thalamic glioma and had post radiation necrosis. (A) Voxel on the lesion. (B and C)
single and multiple voxel MRS showed no detectable (Cho), (Cr) or (NAA) with elevated lactate (Lac) peak. Diagnosis was conﬁrmed on
follow up.
606 A. Shokryunit (Signa Horizon, GE medical systems, Milwaukee, Wis-
consin, USA), using a quadrature head coil set as transmitter
and receiver bands.
All the patients underwent multiplanar MRI before and
after IV gadolinium DTPA in a dose of 0.1 ml/kg. On the basis
of MR examinations, volumes of interest for MRS were placed
inside lesions. Central necrotic areas of the lesions, normal
brain tissue, ﬂuid-ﬁlled structures and fat tissue in the skull
bones were avoided when possible. Localized shimming, phasecorrection and water suppression were performed before
acquisition of the spectra. Spectra were also obtained from
the normal tissue of the contralateral hemisphere if was not
affected by suspicious lesion. The pulse sequence used for
MRS was point resolved single volume spectroscopy (PRESS)
with repetition time (TR) 1500 ms and echo time (TE) 35 ms.
Voxel size in most cases was 1.5 · 1.5 · 1.5 cm3 for single voxel
and was 1 · 1 · 1.5 cm3 for multivoxel. Matrix size was
16 · 16 · 1 and ﬁeld of view was 160 · 160 · 15 mm3.
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Fig. 5 (A) , (B) and (C); Angled upslope pattern (normal pattern).
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Fig. 7 Down–upslope pattern (normal pattern).
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The data were recorded for peaks and were used to calculate
the ratios Cho/NAA and Cho/Cr which were analyzed and
compared with histopathologic diagnosis.
Quantitative analysis of spectra was done for myoinositol
(at 3.5 ppm), choline (at 3.2 ppm), creatine (at 3 ppm), N acet-
ylaspartate (at 2 ppm), alanine (at 1.4 ppm), lipid (at 1–
1.4 ppm) and lactate (at 1.3 ppm) (6).
Metabolite resonance intensities were determined from ﬁt-
ting peak areas. When metabolite resonance intensities were
markedly decreased and not determined automatically (void
signal), the signal intensities were estimated manually from
the ﬁtting peak areas using the graded scale on the monitor
or on the ﬁlm. These values were then placed into Cho/NAA
and Cho/Cr ratios. MRS data were taken from the normal side
in 7 cases of group (A) and in 3 cases of group (D).
2.4. Comparison with operative data and histologic examination
MRS data were analyzed and compared with the histopatho-
logic diagnosis for all cases of brain glioma. The histopathologic
grade was obtained after previous stereotactic or open surgery.According to WHO classiﬁcation, cases of glioma were graded
as grade 1 (pilocytic astrocytoma), grade 2 (oligodendrogli-
oma), grade 3 (anaplastic glioma including anaplastic oligoastr-
ocytoma and anaplastic oligodendroglioma) and grade 4
(glioblastoma multiforme) (7).
Based on clinical standards, grade I/II glioma is categorized
as low grade glioma, while grade III/IV glioma is categorized
as high grade glioma.
2.5. Statistical analysis
Statistical calculations were performed using statistical soft-
ware, Student and Variance tests. The mean ratios of Cho/
NAA and Cho/Cr were compared between tumor grades using
a parametric analysis. Metabolic ratios are also compared be-
tween cases of high grade glioma and cases of metastases. Sta-
tistically signiﬁcant mean differences were considered at a P
value <0.05.
2.6. Diagrammatic representations (suggested by the author)
Diagrammatic representations were obtained from the normal
brain MRS data (taken from the normal contralateral hemi-
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Fig. 11 Straight upslope pattern (post radiation necrosis).
608 A. Shokryspheres of 7 patients of group A and 3 patients of group D),
from MRS data of cases of brain glioma (group A) and from
cases of post radiation necrosis (group D). These were ob-
tained simply using Microsoft Excel program of the computer,
by drawing lines from left to right connecting the Cho, Cr and
NAA peak values with the exclusion of myoinositol (M Ino)
peak to make a diagram for every case. MRS data of normal
brain, viable tumors of group A and of cases of post radiation
necrosis of group D were represented by diagrams to give a
simpliﬁed diagnostic approach. Myo-Inositol was excluded in
this work as it has no signiﬁcant value in brain gliomas.
Diagrammatic representations were summarized into 5
patterns:
Upslope pattern: included straight or angled upslope and
upslope associated with ﬂat patterns.
Up–down slope pattern: included upslope followed by
downslope patterns.
Flat pattern: included single ﬂat pattern.
Down slope pattern: included straight or angled downslope
and downslope associated with ﬂat patterns.
Down–upslope pattern (v shaped pattern): includes down
slope followed by upslope patterns.8.5
9
9.5
10
10.5
A
Fig. 10 (A) and (B); Angled upslopeIf ﬂat pattern was associated with any other pattern it was
named according to the associated one.3. Results
Patients of group (A) were: 15 patients with brain glioma
including 6 patients with grade 4 tumors (glioblastoma multi-
forme), 4 patients with grade 3 tumors (anaplastic glioma), 3
patients with grade 2 tumors (oligodendroglioma) and 2 pa-
tients with grade 1 tumors (pilocytic astrocytoma).
Patients of group (B) were: 10 patients with meningioma.
Patients of group (C) were: 10 patients with brain metasta-
ses (4 cases from bronchogenic carcinoma, 3 cases from breast
carcinoma, 2 cases from renal cell carcinoma and 1 case from
gastric carcinoma).
Patients of group (D) were: 7 cases of treated glioma with
post radiation necrosis.
The summary of MRS ﬁndings, pathology data and tumor
grades for cases of brain glioma were presented in Table 1. Ta-
ble 2 showed mean metabolic ratios in brain glioma (group A).
Table 3 showed MRS data from normal contra lateral side in
group (7 cases of group A), while Table 4 showed the mean
data ratios of Cho/NAA and Cho/Cr in normal hemispheres
of 7 patients of group A. Table 5 showed MRS data in 7 pa-
tients of group (D) diagnosed as post radiation necrosis. Mean
ratios in the same group were shown in Table 6. MRS data
from normal contra lateral side in 3 patients from group (D)
and their mean ratios were seen in Tables 7 and 8.
The mean metabolic ratios of Cho/NAA and Cho/Cr in
grade 4 gliomas were 3.63 and 3.99 respectively. Mean meta-
bolic ratios of Cho/NAA and Cho/Cr in grade 3 tumors were
2.82 and 2.06 respectively, while ratios in grade 2 tumors were
1.70 and 1.75 respectively. In grade 1 astrocytoma mean ratios0
5
10
15
B
pattern (post radiation necrosis).
010
20
30
40
50
0
20
40
60
80
BA
Fig. 12 Angled downslope pattern (glioma).
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Fig. 13 Down–upslope pattern or V shaped pattern (glioma).
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Fig. 14 Summary of diagrams suggested by the author. (A), (B)
benign lesion (normal or post radiation necrosis), (C), (D) post
radiation necrosis, (E), (F) tumor, (G) and (H) normal or tumor.
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average Cho/NAA and Cho/Cr ratios taken from the normal
hemispheres of patients of group (A) were 0.57 and 0.84
respectively, while the average ratios taken from the normal
hemispheres of patients of group (D) were 0.66 and 0.84
respectively. Average Cho/NAA ratios were 2.76 for brain gli-
oma and 0.62 for post radiation injury, while mean Cho/Cr ra-
tios were 2.71 and 0.74 respectively. The Cho/Cr and Cho/
NAA ratios were signiﬁcantly higher in tumors than in radia-
tion injury or normal brain. Values higher than 1.5 for either
Cho/Cr or Cho/NAA ratios were consistent with tumors and
values higher than 2 were consistent with high grade glioma.
Cases of metastases showed Cho/Cr or Cho/NAA ratios
more than 2 and were similar to cases of high grade glioma.
A lipid dominant peak was observed in 7 of 10 cases of
metastases (70%). This presentation was seen only in 1 case
of high grade glioma (6.6% of cases of glioma).
In 4 of 10 cases of metastases (40%) there was marked
reduction or absent creatine.
Dominant alanine peak (at 1.4 ppm) was the characteristic
of meningioma, seen in 8 cases with triple alanine peaks (from
1.2 to 1.6 ppm) seen in 5 cases.
Figure 1 showed MRS spectra of a normal brain taken
from the normal contralateral hemisphere while Figs. 2–13
showed different patterns of MRS data and diagrammatic
representations.
Figures 14 and 15 showed a summary of suggested dia-
grams and a diagnostic approach suggested by the author.
Number of cases and % of different diagrammatic patterns
of MRS data for normal brain, brain glioma and necrosis were
shown in Table 9.
MRS metabolic ratios in cases of high grade glioma and
cases of metastases were shown in Table 10.4. Discussion
There is strong evidence that MRS signal patterns can help in
determining of tumor type and grade (1).
Fig. 15 Summary of the diagnostic approach suggested by the author.
Table 9 Number of cases and % of different diagrammatic
patterns.
Pattern Normal Necrosis Glioma
Upslope 8 cases = 80% 4 cases = 57.14% –
Up–down slope 1 case = 10% – –
Flat – 3 cases = 42.86% –
Down slope – – 9 cases = 60%
Down–upslope 1 case = 10% – 6 cases = 40%
610 A. ShokryNo enough studies are available concerning the application
of Cho/Cr, and Cho/NAA ratios in staging of brain tumors
with pathology correlation. This study provided a comparative
evaluation of Cho/Cr, Cho/NAA ratios and pathological
grade in the evaluation of brain tumors. Metabolite concentra-
tions can be detected and quantitatively analyzed by MRS (8).
Table 11 showed NAA, Cr, and Cho metabolites that can
be detected on MRS under optimum conditions (6).
Ppm: parts per million = chemical shift, Conc.: concentra-
tion in milli mole per kg wet weight.
The mean values for normal NAA/Cr, Cho/Cr, and NAA/
Cho ratios were 1.44, 0.66 and 2.20 respectively (9).
In tumors, Cho levels increase because of increased mem-
brane synthesis and proliferation, while NAA levels fall be-
cause neurones and axons are impaired and destroyed (5).There is also a fall in Cr levels in tumors because of energy
exhaustion and rise in lipids from necrosis (2).
The presence of lipid or lactate resonances in the MR spec-
tra was not predictive for tumor growth since necrosis can re-
sult from tumor progression or radiation injury, therefore they
could not be used for the differentiation of these lesions
(1,5,10).
Results of this study showed that grade 4 glioma had mean
Cho/NAA and Cho/Cr ratios higher than grade 3 and ratios
were two times higher or more, than ratios of grade 1 or 2.
The estimated metabolite concentrations reported in this study
were, in general, in good agreement with the prior literature
values (1,2,10).
In grade 4 gliomas, the mean Cho/NAA and Cho/Cr ratios
in this study were 3.63 and 3.99 respectively. In grade 3 tu-
mors, ratios were 2.82 and 2.06 respectively, while in grade 2
tumors, the ratios were 1.70 and 1.75 respectively. In grade 1
astrocytoma, ratios were 1.62 and 1.58 respectively, so grade
4 tumors had the highest ratios and the grade 1 astrocytoma
had the lowest. MRS is well known for differentiating residual
or recurrent tumor from post radiation necrosis. Usually, a
high Cho peak indicates tumor progression and low Cho peak
indicates radiation necrosis. Results of this study showed that
the mean Cho/Cr ratios were 0.74 for post radiation injury,
0.84 for normal brain and 2.71 for tumors. The mean Cho/
NAA ratios were 0.62, 0.60 and 2.76 for post radiation injury,
Table 10 MRS metabolic ratios in cases of high grade glioma
and cases of metastases (mean + standard deviation).
Metabolic ratios High grade glioma
(6 cases)
Metastasis
(10 cases)
P value
Cho/Cr 3.9 ± 2 2.8 ± 1.2 <.05
Cho/NAA 3.6 ± 1 2.6 ± 1.1 <.05
Table 11 NAA, Cr, and Cho metabolites observed with brain
MRS.
Metabolite ppm Conc. (mM/kgww)
Cho 3.19 1.5–2.5
Cr 3.03 5.1–10.6
NAA 2.01 7.9–16.6
ppm: parts per million = chemical shift, Conc.: concentration in
milli mole per kg wet weight.
MRS of brain tumors: Diagrammatic representations and diagnostic approach 611normal brain tissue and brain tumors respectively. Cho/Cr and
Cho/NAA ratios were signiﬁcantly higher in tumors than in
normal brain and post radiation injury. Ratios higher than
1.5 for either Cho/Cr or Cho/NAA were diagnostic of tumor
and ratios higher than 2 were suggestive of high grade glioma.
This agrees with Weybright et al. 2005 (11), who stated that the
Cho/Cr and Cho/NAA ratios were signiﬁcantly higher, in tu-
mor than in post radiation injury or normal brain tissue.
A lipid dominant peak was observed in 7 of 10 cases of
metastases in this study (70%). This presentation was seen
only in 1 case of high grade glioma (6.6% of cases of glioma).
A lipid dominant peak was observed in 7 of 10 cases of
metastases (70%). This presentation was only seen in 1 case
of high grade glioma (6.6% of cases of glioma).
In 4 of 10 cases of metastases in this study (40%), there was
marked reduction or absent creatine.
Dominant alanine peak (at 1.4 ppm) was characteristic of
meningioma in this study, seen in 8 cases (with triple alanine
peaks from 1.2 to 1.6 ppm seen in 5 cases). These ﬁndings
agree with previous reports (12, 13).
In a trial to simplify the diagnostic approach of MRS, dia-
grammatic representations were obtained for MRS data. To
the author’s knowledge, previous representations were not sat-
isfactory. Hunter’s angle was suggested by a line connecting
the M-Ino, Cho, Cr and NAA peaks to make an angle with
the horizontal plane. When the metabolites were present in
normal proportions, the angle will be 45 . In tumors the angle
was more than 50 (14). This was not practical in determining
tumor grade.
Simple diagrammatic representations were suggested in this
study by imagining lines connecting peak points of Cho, Cr and
NAA from left to right on the MRS (excluding myoinositol) to
get a diagnostic diagram. If ﬂat pattern is associated with any
other pattern it is named according to the associated one.
From diagrammatic representations and metabolic ratios
the following approach is suggested by the author to diagnose
and grade gliomas and to differentiate it from post radiation
necrosis or surrounding normal brain tissue:
 Upslope pattern (straight or angled) was suggestive of
benign lesion (normal or necrosis) and tumor is excluded. Up–down slope pattern could be seen in few normal cases
and can be considered as upslope pattern.
 Flat pattern was suggestive of necrosis.
 Down slope pattern (straight or angled) is suggestive of
tumor, then ratios can differentiate tumor grade (Cho/Cr,
Cho/NAA ratios below 2 suggest low grade tumors, while
ratios above 2 suggest high grade tumors).
 Down–upslope pattern (v shaped pattern) is a non speciﬁc
pattern (seen in 10% of normal cases and in 40% of
tumors), then Cho/Cr and Cho/NAA ratios can differenti-
ate (ratios below 1.5 suggest normal brain, ratios above
1.5, below 2 suggest low grade glioma and ratios above 2
suggest high grade glioma or metastases).
The observations in this study have been supported by pre-
vious reports and published studies (1,2,10–13).
5. Conclusion
MRS metabolic ratios (Cho/Cr and Cho/NAA) can be used to
grade and differentiate gliomas. Ratios less than 1.5 suggest
necrotic or normal brain tissue; ratios from 1.5 to 2 suggest
low grade glioma and ratios higher than 2 suggest high grade
glioma or metastasis. Metastases were similar to high grade gli-
oma but with more lipid peak and may be with absent creatine.
Meningioma had a characteristic alanine peak.
Simple diagrammatic representations and a diagnostic
approach were suggested in this study. Simple software can be
added to the MR machine in the future to plot these diagram-
matic representations with the MRS data. With the widespread
application of Picture Archiving and Communications Systems
(PACS), this could be made easily by the computer system.
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